Healthcare >> CEO Interviews >> October 26, 2004
SHERRI C. OBERG is President and Chief Executive Officer and a co-
founder of Acusphere, Inc., a specialty pharmaceutical company,
developing drug candidates for cardiology, oncology and asthma. Prior to
founding Acusphere, she was CEO of Neomorphics, Inc., a venture capital-
backed company focused on tissue engineering. Prior to Neomorphics, she
was a venture capitalist, first at Inco Venture Capital Management and
then at Aegis Venture Funds, where she focused on biomedical
investments. Ms. Oberg received a BA from Dartmouth College and MBA from
the Amos Tuck School of Business Administration. She serves on the Board
of Overseers of the Amos Tuck School, and on the Advisory Board for the
Center for Private Equity and Entrepreneurship at the Tuck School of
Business at Dartmouth College. Profile
your technology and products.
Ms. Oberg: The company was started in 1993 by myself and Bob Langer, who
is a very prominent
